639
Views
33
CrossRef citations to date
0
Altmetric
Letter to the Editor

Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine

, MBBS, , MMed, , MBBS, , MBBS, , FRCSEdORCID Icon & , FRCSEd
Pages 1212-1215 | Received 05 Aug 2021, Accepted 24 Aug 2021, Published online: 10 Sep 2021
 

ABSTRACT

A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.